Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Patricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, María Laura García Martinez, Ana Gabriela Aranguré Peraza, Manuel Bousiéguez, Tara Shochet & Beverly Winikoff. (2014) Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City. Reproductive Health Matters 22:sup44, pages 75-82.
Read now
Read now
Ilana G. Dzuba, Beverly Winikoff & Melanie Peña. (2013) Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean. The European Journal of Contraception & Reproductive Health Care 18:6, pages 441-450.
Read now
Read now
R. J. McKay & L. Rutherford. (2013) Women's satisfaction with early home medical abortion with telephone follow-up: A questionnaire-based study in the UK. Journal of Obstetrics and Gynaecology 33:6, pages 601-604.
Read now
Read now
Sheila Raghavan, Galina Maistruk, Tara Shochet, Vladimir Bannikov, Svetlana Posohova, Svetlana Zhuk, Vladimir Lishchuk & Beverly Winikoff. (2013) Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials. The European Journal of Contraception & Reproductive Health Care 18:2, pages 112-119.
Read now
Read now
Sheila Raghavan, Tamar Tsereteli, Asamidin Kamilov, Dilfuza Kurbanbekova, Dilmurod Yusupov, Feruza Kasimova, Dilbar Jymagylova & Beverly Winikoff. (2013) Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan. The European Journal of Contraception & Reproductive Health Care 18:2, pages 104-111.
Read now
Read now
Articles from other publishers (26)
Laila Carolina Abu Esba, Ghada Al Mardawi, Elham Al Mardawi, Fay Musaed Almadhi & Husam I. Ardah. (2023) Misoprostol-Induced Fever and Unnecessary Antibiotic Prescribing: A Retrospective Study. Infectious Diseases and Therapy 12:9, pages 2259-2268.
Crossref
Crossref
Samuel Martin Eckstein, Stefanie von Felten, Laura Perotto, Romana Brun & Denise Vorburger. (2023) First trimester abortion protocols by facility type in Switzerland and potential barriers to accessing the service. Scientific Reports 13:1.
Crossref
Crossref
Yutaka Osuga, Kazuhiro Shirasu, Ruriko Tsushima & Ken Ishitani. (2023) Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study. Reproductive Medicine and Biology 22:1.
Crossref
Crossref
Ilana G. Dzuba, Philicia W. Castillo, Manuel Bousiéguez, Elba Margarita Lugo Hernández, José Juan Castañeda Vivar & Patricio Sanhueza Smith. (2020) A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64–70 and 71–77 days of gestation: A retrospective chart review. Contraception 102:2, pages 104-108.
Crossref
Crossref
Ilana G. Dzuba, Erica Chong, Curtiss Hannum, E. Steve Lichtenberg, Elba Margarita Lugo Hernández, Nguyen thi Nhu Ngoc, Ashlesha Patel, Gulnara Rzayeva, Patricio Sanhueza Smith, George Tsertsvadze & Beverly Winikoff. (2020) A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64–70 days and 71–77 days of gestation. Contraception 101:5, pages 302-308.
Crossref
Crossref
Jennifer K Hsia, Patricia A Lohr, Jeanette Taylor & Mitchell D Creinin. (2019) Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation. Contraception 100:3, pages 178-181.
Crossref
Crossref
Amanda Larsson & Ann‐Kristin M. Ronnberg. (2019) Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety. Acta Obstetricia et Gynecologica Scandinavica 98:6, pages 747-752.
Crossref
Crossref
Sarah Warden, Inna Genkin, Susan Hum & Sheila Dunn. (2019) Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting. Journal of Obstetrics and Gynaecology Canada 41:5, pages 647-652.
Crossref
Crossref
Philip Goldstone, Clara Walker & Katherine Hawtin. (2017) Efficacy and safety of mifepristone–buccal misoprostol for early medical abortion in an Australian clinical setting. Australian and New Zealand Journal of Obstetrics and Gynaecology 57:3, pages 366-371.
Crossref
Crossref
Cui-Lan Li, Li-Ping Song, Shi-Yan Tang, Lee Jaden Gil Yu-Kang Zhou, Hong He, Xue-Tang Mo & Yi-Ming Liao. (2017) Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial. Reproductive Sciences 24:5, pages 731-737.
Crossref
Crossref
K. Bettahar, A. Pinton, T. Boisramé, V. Cavillon, S. Wylomanski, I. Nisand & D. Hassoun. (2016) Interruption volontaire de grossesse par voie médicamenteuse. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 45:10, pages 1490-1514.
Crossref
Crossref
Maria Hedqvist, Lina Brolin, Tanja Tydén & Margareta Larsson. (2016) Women's experiences of having an early medical abortion at home. Sexual & Reproductive Healthcare 9, pages 48-54.
Crossref
Crossref
Ingrida Platais, Tamar Tsereteli, Galina Grebennikova, Tatyana Lotarevich & Beverly Winikoff. (2016) Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan. International Journal of Gynecology & Obstetrics 134:3, pages 268-271.
Crossref
Crossref
Dustin Costescu, Édith Guilbert, Jeanne Bernardin, Amanda Black, Sheila Dunn, Brian Fitzsimmons, Wendy V. Norman, Helen Pymar, Judith Soon, Konia Trouton, Marie-Soleil Wagner & Ellen Wiebe. (2016) Avortement médical. Journal of Obstetrics and Gynaecology Canada 38:4, pages 390-420.
Crossref
Crossref
Dustin Costescu, Edith Guilbert, Jeanne Bernardin, Amanda Black, Sheila Dunn, Brian Fitzsimmons, Wendy V. Norman, Helen Pymar, Judith Soon, Konia Trouton, Marie-Soleil Wagner & Ellen Wiebe. (2016) Medical Abortion. Journal of Obstetrics and Gynaecology Canada 38:4, pages 366-389.
Crossref
Crossref
Natalie S. Whaley & Anne E. Burke. (2015) Update on medical abortion. Current Opinion in Obstetrics & Gynecology 27:6, pages 476-481.
Crossref
Crossref
Lawren Wellisch & Julie Chor. (2015) Adolescent Girls and Abortion. Pediatric Annals 44:9, pages 384-392.
Crossref
Crossref
Elizabeth G. Raymond, Daniel Grossman, Ellen Wiebe & Beverly Winikoff. (2015) Reaching women where they are: eliminating the initial in-person medical abortion visit. Contraception 92:3, pages 190-193.
Crossref
Crossref
Dina Abbas, Erica Chong & Elizabeth G. Raymond. (2015) Outpatient medical abortion is safe and effective through 70days gestation. Contraception 92:3, pages 197-199.
Crossref
Crossref
Kelly Cleland & Nicole Smith. (2015) Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data. Contraception 92:3, pages 179-181.
Crossref
Crossref
Melissa J. Chen & Mitchell D. Creinin. (2015) Mifepristone With Buccal Misoprostol for Medical Abortion. Obstetrics & Gynecology 126:1, pages 12-21.
Crossref
Crossref
Thoai D. Ngo, Caroline Free, Hoan T. Le, Phil Edwards, Kiet H.T. Pham, Yen B.T. Nguyen & Thang H. Nguyen. (2014) Knowledge and provision practices regarding medical abortion among public providers in Hanoi, Khanh Hoa, and Ho Chi Minh City, Vietnam. International Journal of Gynecology & Obstetrics 124:3, pages 216-221.
Crossref
Crossref
Amy G. Bryant, Elizabeth Regan & Gretchen Stuart. (2014) An Overview of Medical Abortion for Clinical Practice. Obstetrical & Gynecological Survey 69:1, pages 39-45.
Crossref
Crossref
Ning Ji, You Zhou, Ying Zhang, Dian He, Cheng Pang, Maomao Xi & Yimin Cheng. (2012) Medical abortion service in rural areas of Henan Province, China: A provider survey. Journal of Obstetrics and Gynaecology Research 39:3, pages 672-679.
Crossref
Crossref
Elizabeth G. Raymond, Caitlin Shannon, Mark A. Weaver & Beverly Winikoff. (2013) First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception 87:1, pages 26-37.
Crossref
Crossref
Karen Pazol, Andreea A. Creanga & Suzanne B. Zane. (2012) Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001–2008. Contraception 86:6, pages 746-751.
Crossref
Crossref